2.3. Percentage of Plasmacytoid BDCA-2+CD123+ DCs with PD-L1 or PD-L2 Expression in PB, PF, and among Ovarian Cancer Infiltrating Cells. This evidence concerns the gene PDCD1LG2 and ovarian carcinoma.